iBio (IBIO) Operating Expenses (2010 - 2026)

iBio (IBIO) has 17 years of Operating Expenses data on file, last reported at $8.4 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 71.45% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $29.3 million, a 70.23% increase from a year earlier, with the FY2025 full-year figure at $19.0 million, up 12.71% from the prior year.
• Operating Expenses for Q1 2026 stood at $8.4 million, down from $9.4 million in the prior quarter.
• Over the last five years, Operating Expenses for IBIO reached as high as $10.6 million in Q4 2022 and fell as low as $3.6 million in Q2 2024.
• Historically, Operating Expenses has averaged $6.4 million across 5 years, with a median of $5.4 million in 2025.
• Across the five-year window, Operating Expenses slumped 57.48% in 2023 and soared 104.48% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $10.6 million in 2022, then plunged by 57.48% to $4.5 million in 2023, then gained by 2.74% to $4.6 million in 2024, then surged by 104.48% to $9.4 million in 2025, then dropped by 11.43% to $8.4 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $8.4 million in Q1 2026, $9.4 million in Q4 2025, and $6.1 million in Q3 2025.